Summit Therapeutics Reports Financial Results For The Second Quarter And Half Year Ended 31 July 2017 And Operational Progress Post author:Sam Post published:August 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bayer Halts Phase III Study on New Xarelto Indication October 5, 2017 Bay Area's Ultragenyx Tanks as Seizure Drug Flunks Phase II Test March 22, 2017 Select Medical Announces Appointment Of To The Board Of Directors February 20, 2017